| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 42.746 | 68.417 | 78.019 | 116.058 | 121.452 | 128.331 | 160.267 | 173.139 |
| Total Income - EUR | - | 0 | 42.747 | 68.598 | 78.020 | 116.280 | 121.693 | 128.867 | 160.320 | 174.429 |
| Total Expenses - EUR | - | 0 | 16.164 | 28.358 | 25.810 | 27.990 | 29.658 | 36.237 | 40.518 | 55.991 |
| Gross Profit/Loss - EUR | - | 0 | 26.583 | 40.240 | 52.209 | 88.291 | 92.035 | 92.631 | 119.802 | 118.438 |
| Net Profit/Loss - EUR | - | 0 | 26.156 | 39.554 | 51.429 | 87.129 | 90.819 | 91.342 | 118.198 | 113.205 |
| Employees | - | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Fanirimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 529 | 466 | 405 | 355 | 303 | 250 |
| Current Assets | - | 45 | 27.546 | 41.041 | 52.225 | 88.644 | 177.504 | 95.528 | 145.415 | 154.864 |
| Inventories | - | 0 | 42 | 0 | 63 | 59 | 66 | 0 | 3 | 0 |
| Receivables | - | 0 | 3.561 | 5.941 | 2.352 | 9.506 | 8.929 | 71.453 | 136.817 | 115.472 |
| Cash | - | 45 | 23.943 | 35.099 | 49.810 | 79.079 | 168.509 | 24.075 | 8.595 | 39.392 |
| Shareholders Funds | - | 45 | 26.199 | 39.701 | 51.586 | 87.294 | 176.176 | 91.382 | 118.244 | 113.247 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 0 | 1.347 | 1.340 | 1.167 | 1.817 | 1.732 | 4.500 | 27.474 | 41.867 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Fanirimed Srl